Zeng Zeng, Chen Cong-Xian
Cancer Center, Department of Ultrasound Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Zhejiang University School of Medicine, Hangzhou, China.
Front Oncol. 2023 Apr 14;13:1164266. doi: 10.3389/fonc.2023.1164266. eCollection 2023.
Metabolomic analysis is a vital part of studying cancer progression. Metabonomic crosstalk, such as nutrient availability, physicochemical transformation, and intercellular interactions can affect tumor metabolism. Many original studies have demonstrated that metabolomics is important in some aspects of tumor metabolism. In this mini-review, we summarize the definition of metabolomics and how it can help change a tumor microenvironment, especially in pathways of three metabonomic tumors. Just as non-invasive biofluids have been identified as early biomarkers of tumor development, metabolomics can also predict differences in tumor drug response, drug resistance, and efficacy. Therefore, metabolomics is important for tumor metabolism and how it can affect oncology drugs in cancer therapy.
代谢组学分析是研究癌症进展的重要组成部分。代谢组学的相互作用,如营养物质的可利用性、物理化学转化和细胞间相互作用,会影响肿瘤代谢。许多原创研究表明,代谢组学在肿瘤代谢的某些方面具有重要意义。在这篇小型综述中,我们总结了代谢组学的定义以及它如何有助于改变肿瘤微环境,特别是在三种代谢组学肿瘤的途径中。正如非侵入性生物流体已被确定为肿瘤发展的早期生物标志物一样,代谢组学还可以预测肿瘤药物反应、耐药性和疗效的差异。因此,代谢组学对于肿瘤代谢以及它如何影响癌症治疗中的肿瘤学药物具有重要意义。